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ABSTRACT The interaction of n-propylguanidinium (nPG) with sodium channels has been
further characterized. From experiments at varying temperatures, the Qlo for the sodium
current decay time constant in the two [Na+] gradients is 2.6-2.9 independent of drug. Testing
several nPG concentrations we find that peak sodium current declines sharply with [nPG] at
all levels, but the decay time constant approaches an asymptote above 4 mM. No "hooks" in
sodium tail currents are seen. If the sodium current is allowed to decay completely before
repolarization no tail current is observed. We have developed a kinetic model in which nPG
acts at a single site within the sodium channel. Reaction of nPG with its receptor requires two
steps. Fitting the temperature data shows that the first step involves diffusion of the drug to the
site and close association with it. The second step may include molecular reorganization of the
complex. The rate constants for the reaction are all simple exponential functions of voltage.
Using them, the model successfully predicts decay time constants and peak currents, and their
dependence on potential, [Na+] gradient, temperature, and nPG concentration. The results
are consistent with the idea that an arginine residue may be closely associated with
inactivation.
INTRODUCTION
In the previous paper (Lo and Shrager, 1981) we examined n-propylguanidinium (nPG), the
side chain of the amino acid arginine, for its ability to interact with the sodium channel in the
axon membrane. We were especially interested in testing the idea that a peptide with a
cationic amino acid might function as an endogenous blocking particle in the inactivation of
normal sodium channels (Armstrong and Bezanilla, 1977; Rojas and Rudy, 1976; Yeh and
Narahashi, 1977; Eaton et al., 1978; Cahalan and Almers, 1979a,b). nPG perfused internally
resulted in a block of peak sodium conductance and a speeding of INa decay kinetics. Both of
these effects were stronger at higher depolarizations and in axons in which the Na+
concentration gradient was reversed. The results suggested that nPG acted within the sodium
channel and pointed to a double mode of action, possibly at two distinct sites. In order to
further resolve the mechanism involved we now report results of experiments at different
temperatures and drug concentrations, and give records of sodium tail currents. A rather
simple kinetic model requiring just one site is then proposed, as an aid in interpreting the
results.
METHODS
Methods are identical to those of the previous paper (Lo and Shrager, 1981). Crayfish giant axons were
internally perfused and were voltage clamped by an axial wire technique. Experimental pulse protocols
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and ionic current analyses were run by a PDP8 computer. In "normal" [Na+] gradient, [Na+]o = 211.7
mM and [Na+Ji = 15 mM. In "reversed" [Na+] gradient, [Na+]o = 2.3 mM and [Na+]i = 213 or 235
mM. Compositions of all external and internal solutions used are listed in Table I of Lo and Shrager
(1981).
RESULTS
Temperature Dependence
As one means of characterizing the mechanism of action of nPG on sodium channels we have
examined sodium currents of fibers at different temperatures. In Fig. 1 we show the
dependence of INa decay time constant on temperature, drawn as an Arrhenius plot. The
symbols represent experimental data at +90 mV, a potential at which effects of nPG are
large. The straight lines are least-squares fits. Fig. 1 A is from an axon in normal [Na+]
gradient and Fig. 1 B illustrates results in reversed [Na+] gradient. In normal [Na+] gradient
the Q,o for r is 2.9 (control) and 2.6 (nPG). In reversed [Na+] gradient the Qio is 2.6 (control)
and 2.7 (nPG). Therefore, while nPG reduces r by about one-half, the temperature
dependence of this parameter is not significantly changed.
Concentration Dependence
Fig. 2 illustrates an interesting dependence of sodium channel behavior on the concentration
of nPG. Points represent experimental data, recorded in axons in reversed [Na+] gradient. On
the left we plot the ratio of peak currents with and without nPG, and on the right the
corresponding ratio of decay time constants. The abscissa shows the internal concentration of
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FIGURE 1 Temperature dependence of decay time constants. Arrhenius plots of T vs. 1/ T (KO).
Temperature in OC is also indicated. A, axons in normal [Na+] gradient. B, axons in reversed [Na+]
gradient. Symbols represent experimental results from six axons, with depolarizations to +90 mV.
Internal [nPG] = 4.4 mM. Straight lines are least-square fits.
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FIGURE 2 Concentration dependence of nPG on sodium channels. Axons in reversed [Na+] gradient.
Abscissa shows internal nPG concentration. nPG was washed out periodically to check control values. A,
ratio of peak currents with and without drug. B, corresponding ratio of decay time constants. Points
represent experimental data. Open symbols measured at 0 mV; filled symbols at + 100 mV. Lines are
calculated from a kinetic model discussed in the text. Rate constants used for these fits were taken from
the points shown in Fig. 4 B at 0 mV and + 100 mV.
nPG, which ranged from 0.2 to 8 mM. As different concentrations were tested, nPG was
periodically washed out and control values remeasured. Most peak current ratios reflect
averages of bracketing controls to correct for a slow run-down. Open symbols represent data
at 0 mV and filled symbols at + 100 mV. Peak currents decline rapidly with concentration,
even at the highest levels tested. On the other hand, r declines sharply at low [nPG], but
reaches an asymptote above 4 mM. The lines represent fits of a kinetic model that is discussed
below.
FIGURE 3 Sodium tail currents.Axon in normal[(Na ] gradient,with 4.4 mM nPG inside. Pulses to +90
mV were interrupted at times ranging from 0. 1 to 0.7 ms and the potential brought to -70 mV. Traces are
shown here superimposed The fast capacitative transients (30 ss) are not seen on this scale. Tempera-
ture = 80C.
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Tail Currents
In one interpretation of the results described thus far, nPG is driven into Na+ channels when
the membrane is depolarized and the channels open. Other drugs have been found that seem
to act through a similar mechanism. Some of these produce characteristic "hooks" in INa tail
currents when Vm is returned to the holding potential after a depolarization (Yeh and
Narahashi, 1977; Cahalan, 1978). These hooks may be present even if INa has been allowed to
decay completely before repolarization, and kinetic models to explain drug action must
account for these results. Sodium tail currents from an axon in normal [Na+] gradient and
with 4.4 mM nPG internally are shown in Fig. 3. The fiber was depolarized to +90 mV for
varying periods before repolarization to -70 mV. The capacitative transients are too large to
be seen in the figure. No hooks are seen, and tail currents are negligible after decay of INa
during the depolarizing pulse. No tail currents could be recorded from axons in reversed
[Na+] gradients although several voltage protocols were attempted.
KINETIC MODEL
Rate Constants
A model for the interaction of nPG with sodium channels must account for the considerable
variety of phenomena described thus far. In particular, it must explain the action of nPG on
decay time constants, peak conductances, and tail currents, and the dependence of these
effects on voltage, [Na+] gradient, temperature, and nPG concentration. Further, as a test,
we sought a model with a physical interpretation that would be compatible with suggestive
evidence concerning gating mechanisms that has come from other laboratories. This will be
detailed in the Discussion.
We consider that nPG may interact with a receptor in the Na+ channel as outlined below:
k,2 k23
nPG + RI -=R2 R3.
k2, k32
From the results of this and the previous paper (Lo and Shrager, 1981) we conclude that nPG
must interact with the sodium channel through a dual mechanism and we therefore postulate
two steps: the first is a close association of nPG with the receptor (RI) to form the R2 state. R2
then undergoes a change in state to R3. In this model, once nPG is closely associated with the
receptor the channel is blocked, and therefore both R2 and R3 represent closed states.
Analytical solutions for the series reaction RI . R2 i R3 are available and the result for R2
and R3 initially zero is given by Frost and Pearson (1961). We take R1 + R2 + R3 = 1 so that
each Rx represents the fractional occupation of state x. RI (t) is then:
RI(t) = A + B exp (-X2t) + C exp (-X3t)
with A = k2lk32/X2X3
B= k12(X2 - k23- k32)/X2(X2 - X3)
C k12(k23 + k32 - X3)/X3(X2 - X3)
where
X2 = (p + q)/2
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andp = k12 + k2l + k23 + k32
q = [p2 - 4 (kl2k23 + k2lk32 + k2k32)] 1
We wished to see if this scheme could predict the form of Na+ currents recorded in the
presence of nPG. We generated theoretical currents by multiplying control records by R,(t),
where R, is the fraction of Na+ channels not blocked by the drug. In doing so, we include the
assumption that the channel undergoes the normal inactivation process independent of nPG.
The simplest interpretation of this model would be that the nPG receptor may be physically
distinct from the inactivation machinery. The calculation is, however, also consistent with a
common receptor for the drug and an inactivation gating component if the gate kinetics are
not affected by nPG binding. This might be the case, for example, if normal inactivation
involved several groups in addition to the one competing with nPG, and after binding of these
groups, nPG is rapidly displaced. Only channels with open inactivation gates would be
accessible to the drug, and R,(t) would then represent the fraction of these channels not
blocked by nPG. This will be valid so long as the inactivation of some channels does not
increase the effective drug concentration at open channels. For the range of channel densities
reported for large fibers (Levinson and Meves, 1975; Jaimovich et al., 1976) and nPG
concentrations of a few millimolar this would be expected.
In our calculations we also assume that the four rate constants for nPG action change
abruptly with a change in membrane potential, i.e., the drug can interact with channels that
are either resting or activated. Since nPG seems not to be use-dependent (Lo and Shrager,
1981) we have no evidence ruling out interaction with resting channels. We make no
assumptions, however, with regard to a possible coupling of activation and inactivation in Na+
channels. In multiplying control currents by RI we implicitly assume that inactivation
proceeds as in the absence of drug, and require no further assumptions about its nature.
In our attempt to fit this model to the results we began with the dependence of peak
currents and decay kinetics on nPG concentration. We found that the model was capable of
accounting for the steep decline of peak currents and the asymptotic behavior of decay time
constants. This calculation provided initial estimates for the rate constants at several voltages.
The model was then refined by fitting complete sodium currents. The computer varied one
rate constant at a time with increments made progressively smaller in succeeding calculations.
Fits were monitored visually by superimposing records in nPG with model predictions, and
were quantitated by calculating peak values and decay time constants for comparison with
experimental results. We then chose the set of rate constants which, in our judgment, best
satisfied all of the criteria discussed earlier. These are shown as functions of voltage in Fig. 4,
for a temperature of 80C. Fig. 4 A illustrates these parameters for an axon in normal [Na+]
gradient and Fig. 4 B, the corresponding data for reversed [Na+] graident. The points
represent rate constants used by the computer in calculating RI(t) and fitting actual records.
The straight lines are least-square fits to these points. The fits are good, and all rate constants
are simple exponential functions of voltage, at least within the range of Vm examined (-20
to + 120 mV). The voltage dependence of the rate constants for the nPG + RI - R2 reaction
is shallow, and corresponds, at 80C in normal [Na+] gradient, to a site only 6-10% of the
membrane field from the inner surface. The curves for k23 and k32 on the other hand suggest
movement through 20-34% of the field during the R2- R3 transition.
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FIGURE 4 Rate constants used in the kinetic model, plotted vs. membrane potential. A, axons in normal
[Na+] gradient. B, axons in reversed [Na+] gradient. Symbols represent best fits to experimental data.
The straight lines are least-square fits. These rate constants have been used to generate the fitted curves in
Figs. 2, 5, 6, 7, and 8. Units are msr' mM-' for k,2 and msr' for all other rate constants. Temperature -
80C.
- n1 sll '
FIGURE 5 Fits of the model to sodium currents with nPG. Axon in normal [Nat] gradient. The curves
labeled "model" were generated by multiplying control currents by R,(t), calculated using the rate
constants of Fig. 4 A. They are to be compared with the "nPG" curves, which are plotted to the same scale.
The curves with drug have been multiplied by the ratio of driving forces in control/nPG to compensate for
the small difference in reversal potentials, as noted in the previous paper (Lo and Shrager, 1981).
Potassium currents were reduced by 2 mM 4-aminopyridine and eliminated by subtracting records in 100
nM tetrdotoxin. Depolarizations were from -70 mV to -10, +30, +90, and + 110 mV. [nPG] 4.4 mM
internally. Temperature 80C.
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Voltage Dependence
In Fig. 5 we show families of Na+ currents from an axon in normal [Na+] gradient. For
clarity only four voltages are represented: -10, + 30, + 90, + 110 mV. The top family shows
control records. The lower left family gives results with 4.4 mM nPG added internally. Note
different current scales. The lower right family represents a fit of our model to the nPG
curves. Control records were multiplied by R,(t) using the rate constants given in Fig. 4 A for
each Vm. The scale is the same as that for the nPG currents. The fit is satisfactory, predicting
both the decrease in peak currents at all potentials, and the faster decay rate at high
depolarizations. In Fig. 6 we illustrate corresponding data for an axon in reversed [Na+]
gradient. Test pulses were to 0, + 40, + 80, and + 120 mV, and [nPG] was 4.0 mM. Rate
constants used to calculate R,(t) at each Vm are given in Fig. 4 B. The model predicts a decay
time constant that is somewhat too small at the highest depolarization. The peak currents are
fit reasonably well. Note that the current scale is expanded and that there has been a fourfold
decrease from control to nPG.
Detailed peak currents and decay time constants are given in Figs. 7 and 8 for normal and
reversed [Na+] gradients, respectively. The circles show experimental results with nPG
(values without drug are not shown). The crosses give corresponding parameters derived from
fits such as those shown in Figs. 5 and 6, but including more voltages. The lines are smooth
curves joining the crosses and were drawn by eye. The model thus fits records in nPG
satisfactorily, with the few exceptions noted above.
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FIGURE 6 Fits of the model to sodium currents in the presence of nPG. Axon in reversed [Na+] gradient.
The curves labeled "model" have been generated by multiplying control currents by R,(t), calculated
using the rate constants of Fig. 4 B. They should be compared with the "nPG" currents, plotted to the
same scale. Note the large difference from the control scale. Holding potential = -50 mV. A prepulse to
- 1 10 mV for 50 ms and a 0.5 ms return to -50 mV preceded depolarizations to 0, 40, 80, and 120 mV.
[nPG] - 4.0 mM internally. Solutions: Na2.3VH//Na213. Temperature = 80C.
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FIGURE 7 Fit of the model to decay time constants and peak currents. Axon in normal [Na+] gradient.
Crosses were calculated by first generating "model" curves as in Fig. 5 and then measuring t and Ip from
them. The lines were drawn by eye connecting the crosses to indicate trends. The circles represent
experimental values, with [nPG] = 4.4 mM internally. Temperature = 80C.
FIGURE 8 Fit of the model to decay time constants and peak currents. Axon in reversed [Na+] gradient.
Crosses were calculated by first generating "model" curves as in Fig. 6 and then measuring r and Ip from
them. The lines were drawn by eye connecting the crosses to indicate trends. The open circles represent
experimental values, with [nPG] = 4.0 mM internally. Solutions: Na2.3VH//Na213. Temperature =
80C.
Concentration Dependence
Variation of peak currents and decay times with the internal concentration of nPG was
measured at 0 and + 100 mV in axons in reversed [Na+] gradient. Rate constants for our fit
were taken from Fig. 4 B at the corresponding voltages. For calculation of R,(t), k12 was
multiplied by the appropriate concentration of nPG, with the latter incremented in small
steps. After generation of fitted clamp currents, Ipk and r were measured from the fit and are
plotted as the curves in Fig. 2. The model successfully predicts the steep decrease in peak
currents with [nPG] and the corresponding asymptotic behavior of decay time constants.
Model Temperature Dependence
We have tested the model for its ability to account for variation of decay time constants and
peak currents with temperature. We chose fibers for which data were available at both 60 and
1 60C. Rate constants were chosen to fit the nPG curves at + 90 mV and at 60C. The Qlo for Th
measured in control records is given in Table I A and Fig. 1 as 2.89 in normal [Na+] gradient
and 2.55 in reversed [Na+] gradient. If all rate constants were multiplied by 2.89 for a fiber in
normal Na+ gradient (or by 2.55 for reversed [Na+] gradient) then the model gave the time
constant of INa decay at 160C accurately, but predicted too strong a depression of peak
currents. If, however, these high Qlo were used only for the second step of the reaction
sequence (k23 and k32) and a Qio of 1.3, close to that of free diffusion, used for the first step
(k,2 and k20) then the model satisfactorily predicted both Ip and r. Results are summarized in
Table I. Rate constants and QlO used are given in part B of Table I. In part C we give control
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TABLE IA
TEMPERATURE DEPENDENCE OF THE KINETIC MODEL: MEASURED CONTROL Qio
Th
[Na'J gradient QIO
60C 160C
ms ms
Normal 0.211 0.073 2.89
Reversed 0.270 0.106 2.55
TABLE IB
TEMPERATURE DEPENDENCE OF KINETIC MODEL: RATE CONSTANTS
Normal [Na+] gradient Reversed [Na+] gradient
Rate constant
60C Q,0 used 160C 60C Qio used 160C
ms-' ms-' ms-' ms-'
k,2 x InPG]* 14.00 1.30 18.20 32.00 1.30 41.60
k2, 11.00 1.30 14.30 4.50 1.30 5.85
k23 11.00 2.89 31.79 6.50 2.55 16.60
k32 1.00 2.89 2.89 0.14 2.55 0.36
*[nPG] = 4.4 mM
TABLE IC
TEMPERATURE DEPENDENCE OF KINETIC MODEL: DECAY r AND PEAK Na+ CURRENTS
T Ip[Na+] gradient Temp.
Control nPG Model control nPG Model
IC ms ms ms mA/cm2 mA/cm2 mA/cm2
Normal 6 0.211 0.127 0.126 1.36 0.55 0.54
16 0.073 0.047 0.050 3.29 1.75 1.81
Reversed 6 0.270 0.113 0.114 11.15 1.81 1.81
16 0.106 0.041 0.043 17.38 4.22 3.86
values of T and Ip, measurements in nPG, and fits of the model. The "nPG" and "model"
numbers at 160 (underlined pairs) are close in all cases, indicating adequacy of the fit.
Double-pulse Inactivation
In the previous paper (Lo and Shrager, 1981) we compared the kinetics of inactivation
measured from INa decay (Th) with those measured from a double-pulse procedure (f>)
(Goldman and Schauf, 1972). We found that for strong depolarizations nPG reduced rC along
with Th in reversed [Na+] gradient. In normal [Na+] gradient, however,
-rc remained at
control levels in nPG despite decreases in Th. This suggests that the drug is removed from the
channel within 200-500 ,As at -60 to -70 mV when the external [Na+] is high, and that
removal requires >1 ms when the external [Na+] is low.
Applying our kinetic model to double-pulse experiments is difficult since it requires
solutions from various specified initial conditions. We have attempted only rough calculations
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to determine consistency. The reaction was first run "forward" for 100 ,As at +90 mV. Rate
constants at -70 mV were then estimated by extrapolating the curves in Fig. 4, and the
degree of reversal to the RI state was estimated after 200-1,000 ,us. Despite a few
approximations required in this last calculation, it was clear that this procedure could not
account for the differences observed in the different [Na+] gradients. Using the extrapolated
rate constants the model predicts equivalence of rT and Th in both cases. The difficulty may lie
in assuming that the simple exponential dependence on voltage found for the rate constants
above -20 mV holds at more negative potentials. If, in particular, nPG acts only on open
channels, as seems to be the case for drugs showing "use dependence" (Strichartz, 1973;
Hille, 1977; Cahalan and Almers, 1979), then a sharp drop in k12, and possible changes in
other rate constants, would occur in the region of Vm corresponding to activation.
Na+ Tail Currents
Because in our model we postulate that inactivation proceeds independently from nPG block,
no tail currents would be expected if prepulse currents are allowed to decay to zero before
repolarizing. This has been shown to be the case in Fig. 3. If repolarization is effected earlier,
we can estimate the rate at which nPG would leave open channels by extrapolating the rate
constants of Fig. 4 A to -70 mV. In this case the extrapolation may be valid since we are
interested in events at very short times after the change in Vm. At this potential k2I and k32
would each be about 20 ms-' and kl2 and k23 would be much smaller. Thus, nPG would be
expected to leave with a time constant of the order of 50 ,us. This will overlap the fast
capacitative transient, thus masking any "hooks." The model predications are therefore
consistent with the records in Fig. 3.
DISCUSSION
In the previous paper (Lo and Shrager, 1981) it was shown that the speeding of INa decay
kinetics by nPG is insufficient to explain the observed decrease in peak Na+ conductance,
suggesting that nPG acts in at least two ways. This conclusion is strengthened by the results
with varying drug concentrations. The decay time constant approached an asymptote as the
[nPG] rose above 4 mM, while peak Na+ current continued to decline (Fig. 2). We flrst
considered, therefore, a model involving two sites. As has been discussed (Lo and Shrager,
1981), the decrease in both r and Ip is sensitive to Vm and [Na+] gradient, suggesting that
both sites must be within the sodium channel. At one site, nPG would bind rapidly and block
the channel. At the second site, nPG may either alter the rate of closing of the inactivation
gate (13h) or enter the channel with a rate constant comparable to h and block. In the former
case, the increase in Ah could not result simply from electrostatic forces, since the decrease in
decay time constant was not represented by a simple shift along the voltage axis (Lo and
Shrager, 1981). This site must therefore involve a close association with the h-gate, and since
our evidence suggests a locus inside the sodium channel, we consider it unlikely that binding of
nPG will not in itself result in block. Furthermore, results of the double-pulse experiments in
normal [Na+] gradient would require that ah (the rate of opening of the h-gate) be speeded by
nPG at least 50-fold at -70 mV, which may be unreasonable. Consideration of a two-site
model thus leads to the conclusion that both sites must involve block, and that the sites are
characterized by quite different kinetics and dissociation constants. This might well allow
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sufficient freedom to achieve a fit to the data, but it also makes large demands on the channel
structure. We chose, therefore, to try a simpler system.
We sought a model that would involve only one site within the sodium channel, and would
allow a test of the evidence from other laboratories that arginine might be closely associated
with inactivation (see Introduction). The model that has been adopted has two reaction steps,
and the sequence suggests that the first step invovles a binding, or at least a close association
of nPG with a receptor. The second reaction would then represent a change in state of the
bound complex. Our fit to the temperature dependence of nPG action supports this view. The
Qlo fitted to the first step is 1.3, while that for the second step is 2.6 to 2.9. Thus, the reaction:
nPG + RI R2 may reflect diffusion of the drug to the receptor site, and association with it.
Thermodynamic calculations provide supportive evidence. From the rate constants, k12 and
k2l (60C, normal [Na+] gradient) and their Qio we have for the "association" step:
AGO = - 3.2 kcal/mol, AHO = 0 and AS' = + 1 1.2 e.u. The corresponding values for reversed
Na + gradient are -4.1, 0, and + 14.6, respectively. These numbers are very similar to those
for the binding of small aliphatic anions to proteins: e.g., for CH3 - (CH2)6 - COO- and
bovine serum albumin, AGO, AHO, and AS0 are -3.0, 0, and + 10.9, respectively (calculated
from Boyer et al., 1947). The increase in entropy on binding may result in part from altered
hydration order due to a salt linkage and in part from a transfer of the hydrocarbon chain
from water to a more apolar environment in the membrane (Kauzmann, 1959). The second
step (R2 R3) may then represent a conformational change in the receptor or some further
process in binding. The high Q1o for this step corresponds to a high activation energy (15
kcal/mol, normal [Na+] gradient; 17 kcal/mol, reversed [Na+] gradient).
The asymptotic behavior of r with nPG (Fig. 2) is a result of the relative rates of the two
reactions. The first, or association, step occurs rapidly, with a rate proportional to drug
concentration. The R2 state reaches a maximum occupancy within about 50 /is and therefore
has a large influence on peak Na+ conductance. Further association must await filling of the
R3 state, which occurs at a slower rate. Increasing [nPG] above 4 mM fills R2 faster and to a
higher maximum level, resulting in a further decline of peak current. However, after about
100 ,us the R2 -- R3 step becomes rate limiting, and maintains the rate of INa decay.
The dependence of nPG action on [Na+] gradient is explained in the following way. There
is evidence that at least one binding site for Na+ ions exists within the sodium channel, and
that the energy well is located near the external opening of the channel (Strichartz, 1973;
Hille, 1975). The inactivation mechanism, and hence also the receptor for nPG in our model,
is thought to be close to the internal surface (Armstrong et al., 1973; Shrager and Starkus,
1979). In the fit of our model the rate constant most sensitive to the [Na+] gradient is k32. It is
higher by a factor of more than 10 in normal [Na+] gradient (Fig. 4). A sodium ion bound at
a site external to that of nPG might exert sufficient electrostatic force to increase k32
significantly. The difference in activation energy for the R2 - R3 transition between the two
[Na+] gradients is 1.6 kcal/mol at + 100 mV. In the above physical interpretation this would
imply that the drug-receptor complex is closer to the bound Na+ ion in the R3 state than in the
R2 state. In this hypothesis the external Na+ ions have access to their binding site when nPG is
present, but internal Na+ ions can be prevented from traversing the inner portion of the
channel and reaching this site when the drug is within the channel. Thus, high external [Na+]
reduces the effectiveness of nPG, compared with high internal [Na+]. Effects of the [Na+]
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gradient on other rate constants are much weaker. The lower k,2 and higher k2l in normal
[Na'] gradient are also consistent with a raised potential at a site external to the nPG
receptor when a sodium ion is bound.
Perhaps the weakest aspect of our kinetic scheme is the suggestion that inactivation
proceeds at the same rate regardless of the drug-receptor state. This is probably physically
unreasonable, but was included to avoid introducing further degrees of freedom for the fit. It
is also possible that the R3 state represents in itself the displacement of nPG by the normal
inactivation mechanism, or perhaps the gate "closing behind" the drug. Also, as mentioned
earlier, the model assumes no delay for nPG action after a depolarization. We had no direct
evidence that the drug required prior channel activation. Goldman and Schauf (1972) have
found a coupling of inactivation to activation in Myxicola fibers. The demonstration of gating
charge immobilization by Armstrong and Bezanilla (1977) is evidence that normal inactiva-
tion follows activation. However, recent studies in squid (Gillespie and Meves, 1980) and in
crayfish (Bean, 1979) axons suggest that strict coupling of these processes is not likely,
although some activation steps may be required for inactivation of a channel.
The model presented is the simplest system that we were able to develop that would explain
the results of this and the previous paper. There is ample precedent for a two-step reaction in
ligand-receptor interactions. An obvious example relevant to membrane channels is the
binding of acetylcholine to muscle end-plate receptors (Magleby and Stevens, 1972). It is
interesting in this regard that Yeh and Armstrong (1978) found that pancuronium appeared
to interfere with an inactivation-resistant portion of "off" gating current. These authors
postulate that this component of gating current may be associated with a transition that holds
the channel closed during recovery from inactivation.
Our model satisfactorily explains the influence of nPG on peak conductance and on decay
kinetics at a variety of voltages, drug concentrations, Na+ concentrations, and temperatures.
It does so with rate constants that are simple exponential functions of membrane potential. In
developing a simplified model that allowed so thorough a description of the receptor, we
necessarily sacrificed information about possible identity of this site with normal channel
components. As discussed in introducing the scheme, our model cannot distinguish between a
site distinct from inactivation and one that is common to the inactivation system, but obeys
our assumption of independent kinetics. Work from other laboratories provides information
useful for further resolution of these possibilities. From studies of gating charge immobiliza-
tion, Armstrong and Bezanilla (1977) developed a model for sodium channel inactivation. In
response to a depolarization, charge movement during activation renders the internal channel
surface more negative. A membrane component with positive charge, is then attracted to this
site, occluding the channel. These authors found no gating current component associated with
inactivation and the occluding step was therefore considered to be voltage independent. In our
model, the voltage dependence of k12 and k2l suggests that the receptor for nPG is only a small
percentage of the field from the inner surface (see Results). Charge that moved through just
10% of the field and had the slow kinetics of inactivation would be difficult to detect as gating
current. Further, while nPG and other cationic blockers may have to move some distance into
the channel, an endogenous inactivating component may move primarily within the plane of
the membrane. Thus, nPG, and possibly other organic ions (Rojas and Rudy, 1976; Yeh and
Narahashi, 1977; Hille, 1977; Cahalan and Almers, 1979) may interact at a site common to
normal inactivation. Unlike nPG, the other drugs that have been found to block sodium
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channels are generally large, and have no apparent relationship with normally occurring
membrane chemistry. In showing that the side chain of arginine may also result in
"inactivation" we provide a possible biochemical candidate for this component of the
channel.
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